Literature DB >> 7076208

Hemangiopericytoma of the orbit: a clinicopathologic study of 30 cases.

J O Croxatto, R L Font.   

Abstract

The clinical and pathologic features of 30 orbital hemangiopericytomas were reviewed. An effort was made to determine the clincopathologic characteristics that may correlate with the biologic behavior. Histopathologic criteria evaluated included degree of cellularity, nuclear atypia, mitotic activity, tumor size, and the presence of hemorrhage and necrosis. Histopathologically, 16 tumors were classified as benign, five as borderline, and nine as malignant. Follow-up information was obtained in 27 cases (mean duration of follow-up period was five and one-half years). Eight tumors recurred (30 per cent). Five patients died, four with widespread metastases (15 per cent) and one of unrelated causes. Tumors that recurred or metastasized were distributed among all three histologic groups. The interval between the onset of symptoms and metastasis for three of the four lethal tumors was 31 years, 28 years, and 8 1/2 years; in the fourth case it was unknown. For the entire series, the five-year actuarial survival rate was 89 per cent. Although the number of cases is too small to serve as a basis for firm conclusions, the lack of unequivocal correlation between the histologic features and clinical behavior is consistent with the unpredictable behavior of this neoplasm, as concluded by other investigators. Because of the apparent circumscription of most of these tumors, complete surgical excision rather than exenteration is recommended. Metastasis usually develops late in the clinical course of the disease, indicating that long-term follow-up studies are required before a cure can be assumed.

Entities:  

Mesh:

Year:  1982        PMID: 7076208     DOI: 10.1016/s0046-8177(82)80179-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Treatment of recurrent orbital haemangiopericytoma with surgery and proton beam therapy.

Authors:  H C Gear; E G Kemp; A Kacperek; R D Errington
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  [Exophthalmus after orbital haemangiopericytoma removal 18 years ago].

Authors:  G Welsandt; J W U Fries; W Konen; S Roters
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.059

3.  Recurrent hemangiopericytoma and brachytherapy.

Authors:  J W Tijl; L Koornneef; L E Blank
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 4.  [Orbital neoplasia. Part I: Introduction, vascular and neurogenic tumors].

Authors:  M P Schittkowski; N Fichter
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

5.  Haemangiopericytoma of the lacrimal sac: a case report.

Authors:  L Carnevali; F Trimarchi; R Rosso; M Stringa
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

6.  Treatment of aphakic malignant glaucoma using Nd:YAG laser posterior capsulotomy.

Authors:  B C Little
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

7.  Conjunctival haemangiopericytoma.

Authors:  S Sujatha; R Sampath; R E Bonshek; A B Tullo
Journal:  Br J Ophthalmol       Date:  1994-06       Impact factor: 4.638

8.  Minute myopericytoma of the neck: a case report with literature review and differential diagnosis.

Authors:  Tadashi Terada
Journal:  Pathol Oncol Res       Date:  2010-03-20       Impact factor: 3.201

9.  Sinonasal haemangiopericytoma: a case report.

Authors:  Francesco Stomeo; Valeria Fois; Antonio Cossu; Francesco Meloni; Antonio Pastore; Corrado Bozzo
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-09       Impact factor: 2.503

10.  Proptosis in a Healthy Young Woman.

Authors:  Andrew W Francis; Pete Setabutr; Vinay Aakalu
Journal:  JAMA Ophthalmol       Date:  2016-07-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.